Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Zacks Analyst Blog Highlights: Incyte, Celldex, Bristol-Myers, AstraZeneca and Halozyme
The Zacks Analyst Blog Highlights: Incyte, Celldex, Bristol-Myers, AstraZeneca and Halozyme
The Zacks Analyst Blog Highlights: Incyte, Celldex, Bristol-Myers, AstraZeneca and Halozyme
Submitted by
admin
on May 22, 2014 - 8:36am
Source:
Yahoo/Zacks.com
News Tags:
Incyte
Celldex
Bristol-Myers Squibb
AstraZeneca
Halozyme
Headline:
The Zacks Analyst Blog Highlights: Incyte, Celldex, Bristol-Myers, AstraZeneca and Halozyme
Do Not Allow Advertisers to Use My Personal information
